How many insider trades does FilingIQ track for BDSX?

FilingIQ tracks 444 Form 4 insider transactions for BDSX (BIODESIX INC), covering filings from Oct 30, 2020 onwards. 17 of those were filed in the last 90 days.

Are BDSX insiders net buyers or net sellers?

Across the full Form 4 history for BDSX, 82 transactions (18%) were open-market purchases and 134 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BDSX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BDSX in?

BIODESIX INC (BDSX) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $90.48M.

BDSX insider trading

Healthcare

BIODESIX INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

444

Last 90 days

Buys / sells

18% / 30%

Market cap

$90.48M

About BIODESIX INC

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Company website: www.biodesix.com

BDSX insider activity at a glance

FilingIQ has scored 444 insider transactions for BDSX since Oct 30, 2020. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 82 open-market purchases and 134 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BDSX insider trades is 55.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BDSX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading BDSX

Franchi Jean M.

10 trades · score 78.0

Frequently asked

How many insider trades does FilingIQ track for BDSX?: FilingIQ tracks 444 Form 4 insider transactions for BDSX (BIODESIX INC), covering filings from Oct 30, 2020 onwards. 17 of those were filed in the last 90 days.
Are BDSX insiders net buyers or net sellers?: Across the full Form 4 history for BDSX, 82 transactions (18%) were open-market purchases and 134 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BDSX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BDSX in?: BIODESIX INC (BDSX) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $90.48M.

Methodology & sources

Every BDSX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.